Stock Events

Stock Events

Y mAbs Therapeutics (YMAB) Q3 2024 Earnings

12AugConfirmed

Q3 2023

Q4 2023

Q2 2024

Q3 2024

-0.21

-0.15

-0.08

-0.02

Details

Expected EPS

-0.124286

Actual EPS

-0.21

Surprise EPS

-0.09

Surprise Percent

+68.97%

Description

Y mAbs Therapeutics (YMAB) has reported earnings of -0.21 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.